| 1 |
Priyanto H, Chua E, Hutchinson P, Nugraha J, Amin M. A decrease in PPD specific CD4 T cell CD38 and HLA-DR expression in pulmonary tuberculosis patients after 8 weeks of therapy correlates with successful anti-tuberculosis treatment. J Clin Tuberc Other Mycobact Dis 2021;22:100214. [PMID: 33490641 DOI: 10.1016/j.jctube.2021.100214] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 2 |
Lv D, Liu Y, Guo F, Wu A, Mo Y, Wang S, Chu J. Combining interferon-γ release assays with lymphocyte enumeration for diagnosis of Mycobacterium tuberculosis infection. J Int Med Res 2020;48:300060520925660. [PMID: 32527178 DOI: 10.1177/0300060520925660] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 3 |
Zhang J, Zhang Y, Ma Z. In silico Prediction of Human Secretory Proteins in Plasma Based on Discrete Firefly Optimization and Application to Cancer Biomarkers Identification. Front Genet 2019;10:542. [PMID: 31244885 DOI: 10.3389/fgene.2019.00542] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 4 |
Gratama JW. Issue highlights - May 2016. Cytometry B Clin Cytom 2016;90:244-6. [PMID: 27192087 DOI: 10.1002/cyto.b.21379] [Reference Citation Analysis]
|
| 5 |
Garand M, Goodier M, Owolabi O, Donkor S, Kampmann B, Sutherland JS. Functional and Phenotypic Changes of Natural Killer Cells in Whole Blood during Mycobacterium tuberculosis Infection and Disease. Front Immunol 2018;9:257. [PMID: 29520269 DOI: 10.3389/fimmu.2018.00257] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 6 |
Leem AY, Song JH, Lee EH, Lee H, Sim B, Kim SY, Chung KS, Kim EY, Jung JY, Park MS, Kim YS, Chang J, Kang YA. Changes in cytokine responses to TB antigens ESAT-6, CFP-10 and TB 7.7 and inflammatory markers in peripheral blood during therapy. Sci Rep 2018;8:1159. [PMID: 29348638 DOI: 10.1038/s41598-018-19523-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 7 |
Brown RE, Hunter RL, Hwang SA. Morphoproteomic-Guided Host-Directed Therapy for Tuberculosis. Front Immunol 2017;8:78. [PMID: 28210262 DOI: 10.3389/fimmu.2017.00078] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 8 |
Lichtner M, Mascia C, Sauzullo I, Mengoni F, Vita S, Marocco R, Belvisi V, Russo G, Vullo V, Mastroianni CM. Multifunctional Analysis of CD4+ T-Cell Response as Immune-Based Model for Tuberculosis Detection. J Immunol Res 2015;2015:217287. [PMID: 26339657 DOI: 10.1155/2015/217287] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 9 |
Sauzullo I, Mengoni F, Mascia C, Rossi R, Lichtner M, Vullo V, Mastroianni CM. Treatment of latent tuberculosis infection induces changes in multifunctional Mycobacterium tuberculosis-specific CD4+ T cells. Med Microbiol Immunol 2016;205:37-45. [PMID: 26108901 DOI: 10.1007/s00430-015-0424-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 10 |
Clifford V, Zufferey C, Street A, Denholm J, Tebruegge M, Curtis N. Cytokines for monitoring anti-tuberculous therapy: A systematic review. Tuberculosis (Edinb) 2015;95:217-28. [PMID: 25797612 DOI: 10.1016/j.tube.2015.01.003] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
|
